Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sanofi-Aventis US has appointed Paul Chew as its new chief science officer/chief medical officer, US, effective April 1, 2009. Mr Chew was previously president of R&D at Sanofi-Aventis, US.
Subscribe to our email newsletter
As the company’s chief science officer/chief medical officer, Mr Chew will establish a unified medical voice for Sanofi-Aventis US among internal and external stakeholders.
Mr Chew will be responsible for overseeing US medical affairs in addition to his continued oversight of the US R&D organization in coordination with the group in Paris. Further, Mr Chew will be charged with representing accurate and timely clinical and safety information to health authorities, payers, patients and physicians that will foster safe and appropriate use of our products.
Mr Chew’s primary reporting will be to Greg Irace, president and CEO of Sanofi-Aventis US, in addition to Marc Cluzel, group senior vice president of R&D and Jean-Pierre Lehner, group chief medical officer.
Mr Irace said: “In this new role, Paul will be in a position to bring greater scientific and product insights to our organization, greater clarity and dialogue with members of the healthcare system and, ultimately, greater value to patients in the form of improved health outcomes.”